Impact of pneumococcal conjugate vaccination of infants on pneumonia and influenza hospitalization and mortality in all age groups in the United States.
A seven-valent pneumococcal conjugate vaccine (PCV7) introduced in the United States in 2000 has been shown to reduce invasive pneumococcal disease (IPD) in both vaccinated children and adults through induction of herd immunity. We assessed the impact of infant immunization on pneumococcal pneumonia hospitalizations and mortality in all age groups using Health Care Utilization Project State Inpatient Databases (SID) for 1996 to 2006 from 10 states; SID contain 100% samples of ICD9-coded hospitalization data for the selected states. Compared to a 1996-1997 through 1998-1999 baseline, by the 2005-2006 season, both IPD and pneumococcal pneumonia hospitalizations and deaths had decreased substantially in all age groups, including a 47% (95% confidence interval [CI], 38 to 54%) reduction in nonbacteremic pneumococcal pneumonia (ICD9 code 481 with no codes indicating IPD) in infants <2 years old and a 54% reduction (CI, 53 to 56%) in adults ≥65 years of age. A model developed to calculate the total burden of pneumococcal pneumonia prevented by infant PCV7 vaccination in the United States from 2000 to 2006 estimated a reduction of 788,838 (CI, 695,406 to 875,476) hospitalizations for pneumococcal pneumonia. Ninety percent of the reduction in model-attributed pneumococcal pneumonia hospitalizations occurred through herd immunity among adults 18 years old and older; similar proportions were found in pneumococcal disease mortality prevented by the vaccine. In the first seasons after PCV introduction, when there were substantial state differences in coverage among <5-year-olds, states with greater coverage had significantly fewer influenza-associated pneumonia hospitalizations among children, suggesting that PCV7 use also reduces influenza-attributable pneumonia hospitalizations.
Sage Analytica, Bethesda, Maryland, USA.
Lone
L
Simonsen
Robert J
RJ
Taylor
Yinong
Y
Young-Xu
Michael
M
Haber
Larissa
L
May
Keith P
KP
Klugman
D000293:Adolescent; D000328:Adult; D000368:Aged; D002648:Child; D002675:Child, Preschool; D005260:Female; D006760:Hospitalization; D006801:Humans; D007223:Infant; D007252:Influenza Vaccines / Q000008:administration & dosage*; D007251:Influenza, Human / Q000453:epidemiology / Q000401:mortality* / Q000517:prevention & control; D008297:Male; D008875:Middle Aged; D022242:Pneumococcal Vaccines / Q000008:administration & dosage*; D011018:Pneumonia, Pneumococcal / Q000453:epidemiology / Q000401:mortality* / Q000517:prevention & control; D014481:United States / Q000453:epidemiology; D014611:Vaccination; D018074:Vaccines, Conjugate / Q000008:administration & dosage; D055815:Young Adult
D007252:Influenza Vaccines; D022242:Pneumococcal Vaccines; D018074:Vaccines, Conjugate
J Infect Dis. 2000 Mar;181(3):831-7
10720501
Vaccine. 2007 Jan 15;25(5):846-55
17074423
Pediatr Infect Dis J. 2000 Mar;19(3):187-95
10749457
Nat Med. 2004 Aug;10(8):811-3
15247911
Influenza Other Respir Viruses. 2009 Jan;3(1):37-49
19453440
Lancet. 2005 Mar 26-Apr 1;365(9465):1139-46
15794968
Eff Clin Pract. 2002 May-Jun;5(3):143-51
12088294
N Engl J Med. 2003 May 1;348(18):1737-46
12724479
Pediatr Infect Dis J. 2008 Nov;27(11):963-8
18845982
Am J Epidemiol. 1967 Sep;86(2):433-41
6058395
MMWR Morb Mortal Wkly Rep. 2009 Oct 2;58(38):1059-62
19798018
N Engl J Med. 2006 Apr 6;354(14):1455-63
16598044
Pediatr Infect Dis J. 2004 Nov;23(11):1015-22
15545856
Pediatr Infect Dis J. 2010 Jul;29(7):607-12
20589980
Arch Intern Med. 2005 Feb 14;165(3):265-72
15710788
J Infect. 2007 Jun;54(6):530-8
17097147
Lancet. 2010 Jun 5;375(9730):1969-87
20466419
MMWR Morb Mortal Wkly Rep. 2009 Jan 16;58(1):1-4
19145219
Lancet Infect Dis. 2005 Feb;5(2):83-93
15680778
Lancet. 2007 Apr 7;369(9568):1179-86
17416262
Am J Prev Med. 2008 Jan;34(1):46-53
18083450
Eur Respir J. 2004 Jul;24(1):143-9
15293617
Evid Based Med. 2010 Aug;15(4):109-10
20570947
Lancet Infect Dis. 2007 Oct;7(10):658-66
17897608
Pediatrics. 2010 Jul;126(1):e9-17
20547641
J Infect Dis. 1975 Dec;132(6):689-93
811714
Lancet. 2008 Aug 2;372(9636):398-405
18675690
J Infect Dis. 2010 Jan 1;201(1):32-41
19947881
Pediatr Infect Dis J. 2004 Jan;23(1 Suppl):S87-97
14730275
Am J Med. 1987 Jun 19;82(6A):15-9
3591813
J Infect Dis. 2007 Dec 1;196(11):1662-6
18008250
N Engl J Med. 2003 Oct 2;349(14):1341-8
14523142
Vaccine. 2008 Sep 8;26(38):4947-54
18662735
N Engl J Med. 2003 May 1;348(18):1747-55
12724480
JAMA. 2004 Sep 15;292(11):1333-40
15367555
Am J Epidemiol. 2009 Sep 1;170(5):650-6
19625341
JAMA. 2006 Apr 12;295(14):1668-74
16609088